Muto M, Suzuki H, Suzuki Y
Int J Mol Sci. 2024; 25(19).
PMID: 39408691
PMC: 11476402.
DOI: 10.3390/ijms251910340.
Lempicki M, Paul S, Serbulea V, Upchurch C, Sahu S, Gray J
Cell Immunol. 2022; 381:104603.
PMID: 36182705
PMC: 10691782.
DOI: 10.1016/j.cellimm.2022.104603.
Gomez Atria D, Gaudette B, Londregan J, Kelly S, Perkey E, Allman A
J Clin Invest. 2022; 132(13).
PMID: 35579963
PMC: 9246379.
DOI: 10.1172/JCI158885.
Spinosa M, Montgomery W, Lempicki M, Srikakulapu P, Johnsrude M, McNamara C
Am J Pathol. 2021; 191(12):2231-2244.
PMID: 34509440
PMC: 8647430.
DOI: 10.1016/j.ajpath.2021.08.012.
Li G, Zhang Q, Liu Z, Shen H, Zhu Y, Zhou Z
Cancer Cell Int. 2021; 21(1):223.
PMID: 33865370
PMC: 8052726.
DOI: 10.1186/s12935-021-01923-x.
BAFF 60-mer, and Differential BAFF 60-mer Dissociating Activities in Human Serum, Cord Blood and Cerebrospinal Fluid.
Eslami M, Meinl E, Eibel H, Willen L, Donze O, Distl O
Front Cell Dev Biol. 2020; 8:577662.
PMID: 33240880
PMC: 7677505.
DOI: 10.3389/fcell.2020.577662.
Bispecific Antibodies for Multiple Myeloma: A Review of Targets, Drugs, Clinical Trials, and Future Directions.
Caraccio C, Krishna S, Phillips D, Schurch C
Front Immunol. 2020; 11:501.
PMID: 32391000
PMC: 7193016.
DOI: 10.3389/fimmu.2020.00501.
Editorial: Making Science Fun - A Tribute to Our Colleague and Friend, Prof. Antonius G. Rolink (1953-2017).
Eibel H, Winkler T, Ceredig R
Front Immunol. 2019; 9:2915.
PMID: 30619279
PMC: 6306044.
DOI: 10.3389/fimmu.2018.02915.
Inhibition of Membrane-Bound BAFF by the Anti-BAFF Antibody Belimumab.
Kowalczyk-Quintas C, Chevalley D, Willen L, Jandus C, Vigolo M, Schneider P
Front Immunol. 2018; 9:2698.
PMID: 30524439
PMC: 6256835.
DOI: 10.3389/fimmu.2018.02698.
Identification of a new subset of lymph node stromal cells involved in regulating plasma cell homeostasis.
Huang H, Rivas-Caicedo A, Renevey F, Cannelle H, Peranzoni E, Scarpellino L
Proc Natl Acad Sci U S A. 2018; 115(29):E6826-E6835.
PMID: 29967180
PMC: 6055158.
DOI: 10.1073/pnas.1712628115.
A loop region of BAFF controls B cell survival and regulates recognition by different inhibitors.
Vigolo M, Chambers M, Willen L, Chevalley D, Maskos K, Lammens A
Nat Commun. 2018; 9(1):1199.
PMID: 29572442
PMC: 5865128.
DOI: 10.1038/s41467-018-03323-8.
Aiolos Overexpression in Systemic Lupus Erythematosus B Cell Subtypes and BAFF-Induced Memory B Cell Differentiation Are Reduced by CC-220 Modulation of Cereblon Activity.
Nakayama Y, Kosek J, Capone L, Hur E, Schafer P, Ringheim G
J Immunol. 2017; 199(7):2388-2407.
PMID: 28848067
PMC: 5602157.
DOI: 10.4049/jimmunol.1601725.
A Chemoattractant-Guided Walk Through Lymphopoiesis: From Hematopoietic Stem Cells to Mature B Lymphocytes.
Lim V, Zehentmeier S, Fistonich C, Pereira J
Adv Immunol. 2017; 134:47-88.
PMID: 28413023
PMC: 5784265.
DOI: 10.1016/bs.ai.2017.02.001.
Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date.
Lenert A, Niewold T, Lenert P
Drug Des Devel Ther. 2017; 11:747-757.
PMID: 28331294
PMC: 5357079.
DOI: 10.2147/DDDT.S114552.
Antibodies That Block or Activate Mouse B Cell Activating Factor of the Tumor Necrosis Factor (TNF) Family (BAFF), Respectively, Induce B Cell Depletion or B Cell Hyperplasia.
Kowalczyk-Quintas C, Schuepbach-Mallepell S, Vigolo M, Willen L, Tardivel A, Smulski C
J Biol Chem. 2016; 291(38):19826-34.
PMID: 27451394
PMC: 5025672.
DOI: 10.1074/jbc.M116.725929.
Mucosal Humoral Immune Response to SIVmac239∆nef Vaccination and Vaginal Challenge.
Zeng M, Smith A, Shang L, Wietgrefe S, Voss J, Carlis J
J Immunol. 2016; 196(6):2809-18.
PMID: 26864031
PMC: 4779663.
DOI: 10.4049/jimmunol.1500156.
Acute immunomodulatory changes during controlled ovarian stimulation: evidence from the first trial investigating the short-term effects of estradiol on biomarkers and B cells involved in autoimmunity.
Ghirardello A, Gizzo S, Noventa M, Quaranta M, Vitagliano A, Gallo N
J Assist Reprod Genet. 2015; 32(12):1765-72.
PMID: 26466939
PMC: 4681742.
DOI: 10.1007/s10815-015-0588-x.
Treatment of systemic lupus erythematosus patients with the BAFF antagonist "peptibody" blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trials.
Stohl W, Merrill J, Looney R, Buyon J, Wallace D, Weisman M
Arthritis Res Ther. 2015; 17:215.
PMID: 26290435
PMC: 4545922.
DOI: 10.1186/s13075-015-0741-z.
Stoichiometry of Heteromeric BAFF and APRIL Cytokines Dictates Their Receptor Binding and Signaling Properties.
Schuepbach-Mallepell S, Das D, Willen L, Vigolo M, Tardivel A, Lebon L
J Biol Chem. 2015; 290(26):16330-42.
PMID: 25953898
PMC: 4481231.
DOI: 10.1074/jbc.M115.661405.
Effect of TACI signaling on humoral immunity and autoimmune diseases.
Zhang Y, Li J, Zhang Y, Zhang X, Tao J
J Immunol Res. 2015; 2015:247426.
PMID: 25866827
PMC: 4381970.
DOI: 10.1155/2015/247426.